Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Trier – page 5

81 clinical trials in Trier, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Trier at a glance
81
clinical trials
  • Paediatric trials0
  • Research sites1
Type of trial
Recruitment status
Quick filters

81 trials in Trier

Open in trial search
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Merck Sharp & Dohme LLC
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Florbetaben (18F)
  • Sponsor:F. Hoffmann-La Roche AG
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Florbetaben (18F)
  • Sponsor:F. Hoffmann-La Roche AG
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Universitaetsklinikum Heidelberg AöR
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Gilteritinib
  • Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:Frankfurter Institut Fuer Klinische Krebsforschung IKF GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Frankfurter Institut Fuer Klinische Krebsforschung IKF GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Luspatercept
  • Sponsor:Universitaet Leipzig
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Secukinumab
  • Sponsor:Novartis Pharma GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin
  • Sponsor:Travere Therapeutics Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Goethe University Frankfurt
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Ribociclib
  • Sponsor:WSG Women's Cancer Study Group GmbH

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Trier

What the registry says about research in the country

01 Oncology - Gastrointestinal

Innovative clinical trials focusing on colorectal cancer treatments, including studies of novel combination therapies and pre-operative approaches. Research encompasses both early-stage and metastatic disease management.

  • Metastatic colorectal cancer treatments
  • Pre-operative therapy evaluation
  • Post-resection therapeutic strategies
02 Oncology - Thoracic

Advanced research in non-small cell lung cancer treatment, evaluating novel immunotherapy combinations and targeted therapies for various disease stages.

  • First-line metastatic treatments
  • Early-stage disease management
  • Combination immunotherapy approaches
03 Oncology - Women's Health

Comprehensive studies in breast cancer and ovarian cancer, investigating targeted therapies and innovative treatment combinations.

  • Triple-negative breast cancer therapies
  • Advanced ovarian cancer treatments
  • Hormone receptor-positive breast cancer
04 Hematologic Malignancies

Studies evaluating novel therapies for various blood cancers, including lymphoma and leukemia, with focus on targeted treatments and immunotherapies.

  • Chronic lymphocytic leukemia
  • Mantle cell lymphoma
  • Follicular lymphoma
05 Cardiovascular Medicine

Research focused on acute myocardial infarction management, including innovative therapeutic approaches and preventive strategies.

  • Post-heart attack treatments
  • Emergency interventions
  • Preventive therapies
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.